Tag Archives: Natural Killer Cells

Targeting the αv Integrin-TGF-β Axis Improves Natural Killer Cell Function against Glioblastoma Stem Cells

The authors showed that glioblastoma stem cells, but not normal astrocytes, were sensitive to lysis by healthy allogeneic natural killer cells in vitro.
[Journal of Clinical Investigation]
AbstractFull ArticlePress ReleaseGraphical Abstract
Bookmark

No account yet? Register

0
Share

Deficiency of Myostatin Protects Skeletal Muscle Cells from Ischemia Reperfusion Injury

Examining human specimens from free myocutaneous flap transfer demonstrated increased myostatin signaling and tissue damage in terms of apoptotic activity, cell death, tissue edema, and lipid peroxidation.
[Scientific Reports]
Full Article
Bookmark

No account yet? Register

0
Share

Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Anti-Tumor Immunity

Researchers found that the number of β7+ cells decreased significantly in tumor tissue compared with adjacent normal tissue. β7 expression decreased in tumor-derived compared to normal tissue-derived CD8+ T cells.
[Cancer Immunology Research]
Zhang, Y., Xie, R., Zhang, H., Zheng, Y., Lin, C., Yang, L., Huang, M., Li, M., Song, F., Lu, L., Yang, M., Liu, Y., Wei, Q., Li, J., & Chen, J. (2021). Integrin β7 inhibits colorectal cancer pathogenesis via maintaining anti-tumor immunity. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.CIR-20-0879 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Adoptive Cell Therapy of Triple Negative Breast Cancer with Redirected Cytokine-Induced Killer Cells

Scientists exploited cytokine-induced killer cells’ expression of FcγRIIIa in combination with clinical-grade monoclonal antibodies to redirect their lytic activity in an antigen-specific manner, and reported the efficacy of this combined approach against TNBC.
[Oncoimmunology]
Full Article
Bookmark

No account yet? Register

0
Share

Multi-Omic Profiling Reveals Widespread Dysregulation of Innate Immunity and Hematopoiesis in COVID-19

Researchers performed multi-omic single-cell immune profiling of 64 COVID-19 patients across the full range of disease severity, from outpatients with mild disease to fatal cases.
[Journal of Experimental Medicine]
Wilk, A. J., Lee, M. J., Wei, B., Parks, B., Pi, R., Martínez-Colón, G. J., Ranganath, T., Zhao, N. Q., Taylor, S., Becker, W., Stanford COVID-19 Biobank, Jimenez-Morales, D., Blomkalns, A. L., O’Hara, R., Ashley, E. A., Nadeau, K. C., Yang, S., Holmes, S., Rabinovitch, M., … Blish, C. A. (2021). Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. Journal of Experimental Medicine, 218(8). https://doi.org/10.1084/jem.20210582 Cite
Full ArticleGraphical Abstract
Bookmark

No account yet? Register

0
Share

Shoreline Biosciences and BeiGene Announce Strategic Worldwide Collaboration to Develop and Commercialize Genetically Modified Natural Killer (NK) Cell Therapies

Shoreline Biosciences, Inc. and BeiGene, Ltd. announced a worldwide collaboration to develop and commercialize a portfolio of natural killer (NK)-based cell therapeutics with Shoreline’s iPSC NK cell technology and BeiGene’s research and clinical development capabilities for different malignancies.
[nan]
Press Release
Bookmark

No account yet? Register

0
Share

B2M Gene Expression Shapes the Immune Landscape of Lung Adenocarcinoma and Determines the Response to Immunotherapy

Scientists performed an integrative analysis of the mutational and transcriptional profiles of large cohorts of non-small-cell lung cancer patients and found that epigenetic downregulation of B2M was common.
[Immunology]
Zhao, Y., Cao, Y., Chen, Y., Wu, L., Hang, H., Jiang, C., & Zhou, X. (n.d.). B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy. Immunology, n/a(n/a). https://doi.org/10.1111/imm.13384 Cite
Abstract
Bookmark

No account yet? Register

0
Share

Natural Killer Cells in Antiviral Immunity

The authors review recent insights into the role of NK cells in viral infections, with particular emphasis on human studies.
[Nature Reviews Immunology]
Björkström, N. K., Strunz, B., & Ljunggren, H.-G. (2021). Natural killer cells in antiviral immunity. Nature Reviews Immunology, 1–12. https://doi.org/10.1038/s41577-021-00558-3 Cite
Full Article
Bookmark

No account yet? Register

0
Share

ONK Therapeutics and Trinity College Dublin Collaborate in an Enterprise Ireland Funded Project to Optimize Metabolism of NK Cells for Improved Cancer Therapies

ONK Therapeutics Ltd announced that it has been awarded an Innovation Partnership Programme grant by Enterprise Ireland to fund collaborative research at Trinity College Dublin, Ireland, led by Dr. David Finlay to optimize the metabolism and engineering of NK cells for improved cancer therapies.
[ONK Therapeutics]
Press Release
Bookmark

No account yet? Register

0
Share

Cancer Immunotherapy: It’s Time to Better Predict Patients’ Response

The authors critically discuss current knowledge regarding predictive biomarkers for checkpoint inhibitor-based immunotherapy, highlight the missing/unclear links and emphasise the importance of characterising each neoplasm and its microenvironment in order to better guide the course of treatment.
[British Journal of Cancer]
Pilard, C., Ancion, M., Delvenne, P., Jerusalem, G., Hubert, P., & Herfs, M. (2021). Cancer immunotherapy: it’s time to better predict patients’ response. British Journal of Cancer, 1–12. https://doi.org/10.1038/s41416-021-01413-x Cite
Abstract
Bookmark

No account yet? Register

0
Share

MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING

Scientists examined 81 lung cancer patients under immune checkpoint blockade (ICB) treatment and found that patients with MET amplification were resistant to ICB and had a poor progress-free survival.
[Cancer Discovery]
Zhang, Y., Yang, Q., Zeng, X., Wang, M., Dong, S., Yang, B., Tu, X., Wei, T., Xie, W., Zhang, C., Guo, Q., Kloeber, J. A., Cao, Y., Guo, G., Zhou, Q., Zhao, F., Huang, J., Liu, L., Zhang, K., … Lou, Z. (2021). MET amplification attenuates lung tumor response to immunotherapy by inhibiting STING. Cancer Discovery. https://doi.org/10.1158/2159-8290.CD-20-1500 Cite
Abstract
Bookmark

No account yet? Register

0
Share
Share